SUXETHONIUM

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H34N2O4
Molecular Weight	318.4522
Optical Activity	NONE
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	2

SHOW SMILES / InChI

Structure of SUXETHONIUM

Structure Search

SMILES

CC[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)CC

InChI

InChIKey=DIWYJMPVHQDIMM-UHFFFAOYSA-N

InChI=1S/C16H34N2O4/c1-7-17(3,4)11-13-21-15(19)9-10-16(20)22-14-12-18(5,6)8-2/h7-14H2,1-6H3/q+2

HIDE SMILES / InChI

Molecular Formula	C16H34N2O4
Molecular Weight	318.4522
Charge	2
Count

Stereochemistry	MIXED
Additional Stereochemistry	No
Defined Stereocenters	0 / 2
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13689268 | https://www.ncbi.nlm.nih.gov/pubmed/13820234 | https://www.ncbi.nlm.nih.gov/pubmed/791307

Suxethonium is a depolarising muscle relaxant, with low incidence of postoperative muscle pain.

Approval Year

PubMed

PubMed

Title	Date	PubMed
Plasma potassium changes following suxamethonium and suxethonium in normal patients and in patients in renal failure.	1976-10	791307

Patents

Patents

Sample Use Guides

In Vivo Use Guide

150 mg

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:24:16 GMT 2025` Edited by `admin` on `Mon Mar 31 18:24:16 GMT 2025`
Record UNII	MED638SZQB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SUXETHONIUM

Common Name

English

SUXETHONIUM CATION

Preferred Name

English

Suxethonium [WHO-DD]

Common Name

English

SUXETHONIUM ION

Common Name

English

ETHYL(2-HYDROXYETHYL)DIMETHYLAMMONIUM SUCCINATE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C66886

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

Code System Code Type Description

MESH

C013696

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

FDA UNII

MED638SZQB

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

SMS_ID

100000077548

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

NCI_THESAURUS

C87315

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

EVMPD

SUB15440MIG

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

EPA CompTox

DTXSID30866398

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

CAS

67724-50-9

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

PUBCHEM

46037

Created by admin on Mon Mar 31 18:24:16 GMT 2025 , Edited by admin on Mon Mar 31 18:24:16 GMT 2025

PRIMARY

Related Record Type Details


					Z9T30QA7DO

SUXETHONIUM BROMIDE

SALT/SOLVATE -> PARENT


					1M8W6DVG0L

BUTYRYLCHOLINESTERASE

METABOLIC ENZYME -> SUBSTRATE

Comments:

Quickly degraded by plasma butyrylcholinesterase and the duration of effect is usually in the range of a few minutes.


					U5026H7S5S

SUXETHONIUM CHLORIDE

SALT/SOLVATE -> PARENT

Related Record Type Details


					MED638SZQB

ACTIVE MOIETY